Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells
about
Improvement of Arbuscular Mycorrhiza Development by Inoculation of Soil with Phosphate-Solubilizing Rhizobacteria To Improve Rock Phosphate Bioavailability ((sup32)P) and Nutrient CyclingBiological significance of agmatine, an endogenous ligand at imidazoline binding sitesCibenzoline, an ATP-sensitive K(+) channel blocker, binds to the K(+)-binding site from the cytoplasmic side of gastric H(+),K(+)-ATPasePhentolamine inhibits exocytosis of glucagon by Gi2 protein-dependent activation of calcineurin in rat pancreatic alpha -cells.Imidazolines and pancreatic hormone secretion.Potassium channel activators and bronchial asthma.Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.Effects of BRL 38227 on potassium currents in smooth muscle cells isolated from rabbit portal vein and human mesenteric artery.Clonidine inhibits ATP-sensitive K+ channels in mouse pancreatic beta-cells.Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes.Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide-sensitive K+ currents in Xenopus oocytesPhentolamine block of KATP channels is mediated by Kir6.2.Imidazoline antihypertensive drugs: selective i(1) -imidazoline receptors activation.Investigation of morin-induced insulin secretion in cultured pancreatic cells.Potassium channels, imidazolines, and insulin-secreting cells.Characterization of the imidazoline binding site involved in regulation of insulin secretion.Imidazolines stimulate release of insulin from RIN-5AH cells independently from I1- and I2-imidazoline receptors.alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.In vitro mechanism of action on insulin release of S-22068, a new putative antidiabetic compound.Imidazolines and the pancreatic B-cell. Actions and binding sites.Non-specific action of methoxamine on Ito, and the cloned channels hKv 1.5 and Kv 4.2.Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cells.Block of ATP-regulated potassium channels by phentolamine and other alpha-adrenoceptor antagonistsMultiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets.Effects of P1060 and aprikalim on whole-cell currents in rat portal vein; inhibition by glibenclamide and phentolamine.Antagonism of levcromakalim by imidazoline- and guanidine-derivatives in rat portal vein: involvement of the delayed rectifier.Effects of cromakalim on the membrane potassium permeability of frog skeletal muscle in vitroElevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.Effects of BRL 38227 on neurally-mediated responses in the guinea-pig isolated bronchus.Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.Attenuation by phentolamine of hypoxia and levcromakalim-induced abbreviation of the cardiac action potential.Phentolamine inhibits the pacemaker activity of mouse interstitial cells of Cajal by activating ATP-sensitive K+ channels.Characterisation of the effects of potassium channel modulating agents on mouse intestinal smooth muscle.K(+)-channel blockers and coronary vasoconstriction in guinea-pig perfused hearts in-vitro.Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?Beta-adrenoceptor agonists in bronchial asthma: role of k+-channel opening in mediating their bronchodilator effects.
P2860
Q24542518-C463AD45-D354-45BE-9318-4DC192410B6CQ24673628-BB4677D0-FC1B-481C-8621-E703920A95E6Q28366036-664D21EA-EE01-457A-9762-3F87C08A9C5EQ31440408-898EDD92-5E5A-4880-AA4B-3225F093A71EQ33693050-50906F74-AC20-41FD-9605-935915F64409Q35226195-2058AE78-A81F-436B-BF3E-46332697CDEBQ35870817-6C494692-26E6-4DEA-9CCA-1E682894F4FCQ35872166-542A5034-BBC2-421E-BDFE-D999FDBAA907Q35872267-86B02230-D395-4D10-8F33-D7DB76FFE97AQ36324890-09A3C33E-E764-47F8-BEE0-0A13DBD4CA44Q36329554-A701CC73-570A-4C09-9970-9B349BD1DD16Q36612957-4F793A61-F20E-4C98-9835-1197D5AE2045Q37925015-BB3F5461-CB5B-4D4E-ADD6-5109C1EA8113Q38697506-7420EC8C-E256-4E06-93A6-815C47C58DEDQ40483914-4129F0D3-FBA7-4E0A-9555-620BB1B5B4CFQ40483944-407A8A6B-3322-4E17-A503-EE5B3BDF0B39Q40483951-B4607654-706C-4A4B-A719-38B3A742F192Q40884510-FCC5BB88-932C-4FA6-8826-51F1E27E6388Q40918880-237CAA98-F94C-4B98-88BA-775E9891F96AQ40940376-D94FBEB2-41D0-4D20-BD7C-E88A00589A02Q40962992-4DA31D60-C985-45A1-86DD-E572E304B3DAQ41072561-7C53E508-41AE-4016-B6D0-D50E8AD51D52Q41767802-8BD11CF2-0EA0-4012-9D3E-72E1629E905AQ41859848-AA12393D-2AAF-483C-8E4C-65DFF316EE56Q41914553-701677D0-3DB7-4779-AA00-7599D7CAD990Q41957971-4736F338-48D5-45D5-BE45-15275984731DQ41979147-5E839F88-7C21-476D-89D7-D54C2F0003CCQ42031092-7F67EC62-112A-4201-8E77-0405BFA102D7Q42037649-4DE57301-A605-4973-8210-ACC4B977BA83Q42060217-6EE5C857-A6FE-45FB-A083-0A5A6241F282Q42701372-DA017A66-2719-4FCF-AEAA-DDCDCF888896Q42710116-B9900D06-DBB8-474D-9707-0A1C1E7845D3Q42715181-C02BE624-8B58-4495-B907-150ADE63A235Q42920699-FBC9D62F-E6DD-45C2-A159-1A1F714DDAAFQ43111208-7703466A-4F3D-49B0-ADB2-19DC63754314Q43922711-FB1E44FF-DF8B-4922-A821-4385257C3F0FQ46844336-D10D5441-942E-429E-82FC-C4BC6ADE464CQ53150911-9B0F35E2-1FE7-4CD3-9A5C-9546B45399ECQ54041502-43D9B417-F604-4C38-BF14-3C06907DA7F6
P2860
Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Phentolamine and yohimbine inh ...... in mouse pancreatic beta-cells
@ast
Phentolamine and yohimbine inh ...... in mouse pancreatic beta-cells
@en
type
label
Phentolamine and yohimbine inh ...... in mouse pancreatic beta-cells
@ast
Phentolamine and yohimbine inh ...... in mouse pancreatic beta-cells
@en
prefLabel
Phentolamine and yohimbine inh ...... in mouse pancreatic beta-cells
@ast
Phentolamine and yohimbine inh ...... in mouse pancreatic beta-cells
@en
P2860
P1476
Phentolamine and yohimbine inh ...... in mouse pancreatic beta-cells
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1990.TB12099.X
P407
P577
1990-09-01T00:00:00Z